ArticleAnnals of hematology2025
Advantages of AI-based whole blood film scanning for blast detection in markedly leucopenic blood films.
Article in Annals of hematology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
13 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
To evaluate performance of AI-assisted blast detection via whole blood film scanning in cases of severe leukopenia. From August to October 2023, we collected 157 patient specimens with white blood cell (WBC) counts of ≤2.0 × 10⁹/L. We then evaluated and compared the blast detection capabilities of an artificial intelligence-based system (Cygnus instrument) against the CellaVision DI-60 for WBC analysis. Additionally, this study aimed to assess the comparative performance of these two automated blood cell morphology analyzers based on their underlying operational principles. Following manual microscopy confirmation, 17 cases showing ≥ 1 blast cell in peripheral blood smear were identified among 157 specimens with WBC ≤ 2.0 × 10⁹/L. The Cygnus whole-slide scanning mode detected all 17 cases (sensitivity: 100%), whereas the Cygnus 200-cell mode detected only 9 cases (9/17), and the CellaVision DI-60 200-cell mode detected 8 cases (8/17). In leukopenic patients (WBC ≤2.0×10⁹/L), utilizing Cygnus' whole-slide scanning capability substantially improves blast identification rates, potentially enabling earlier detection of hematologic abnormalities.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.